BIOMAT Database Logo BIOMAT Database Logo

Fatal typhlitis secondary to procainamide-induced agranulocytosis. 1984

R M Clary, and W S Beazley, and R W Henley

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D002429 Cecal Diseases Pathological developments in the CECUM. Cecal Disease,Disease, Cecal,Diseases, Cecal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias

Related Publications

R M Clary, and W S Beazley, and R W Henley
[Procainamide induced agranulocytosis].
January 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R M Clary, and W S Beazley, and R W Henley
Procainamide-induced agranulocytosis.
December 1984, Southern medical journal,
R M Clary, and W S Beazley, and R W Henley
Typhlitis complicating methimazole-induced agranulocytosis.
November 1983, Gastrointestinal endoscopy,
R M Clary, and W S Beazley, and R W Henley
Procainamide-induced agranulocytosis and thrombocytopenia.
February 1979, Archives of internal medicine,
R M Clary, and W S Beazley, and R W Henley
Procainamide-induced agranulocytosis differs serologically and clinically from procainamide-induced lupus.
February 1996, Clinical immunology and immunopathology,
R M Clary, and W S Beazley, and R W Henley
Procainamide-induced agranulocytosis with reversible myeloid sensitivity.
January 1984, American journal of hematology,
R M Clary, and W S Beazley, and R W Henley
Anti-myeloid-cell antibody in procainamide-induced agranulocytosis.
May 1984, Lancet (London, England),
R M Clary, and W S Beazley, and R W Henley
Reversible procainamide-induced agranulocytosis twice in one patient.
October 1971, Lancet (London, England),
R M Clary, and W S Beazley, and R W Henley
Agranulocytosis, procainamide, and phenytoin.
April 1984, Annals of internal medicine,
R M Clary, and W S Beazley, and R W Henley
Agranulocytosis following procainamide administration.
August 1969, American heart journal,
Copied contents to your clipboard!